chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Unrelieved chills, fever of 101.50,  severe headache without any relief from Tylenol or Motrin around the clock.  Could not lift left arm.  Down in bed  until today
DIZZINESS LASTING FOR FEW DAYS, PATIENT TOOK A FALL AND ENDED UP IN EMERGENCY ROOM.
Pt was given routine vaccines (DTAP, IPV, HIB, Prevnar) and 2-3 days later, he developed a seizure disorder and developmental delay. Doc 203598 states  that patient has Infantile spasms.
Patient has a history of seizures.  The day after the vaccine she expierenced a seizure, reported to the ER, was treated, and now has no issues.
3 hours after vaccination break out in hives all over body and in eyes. Became worse over 24 hours. Went to ER, received oral prednisone. Went back to Dr on 8/13, received prednisone injection along with Benadryl and other meds. Temp 102.3.
sore throat, gastritis, dizziness, lack of energy, headache, acne breakout, difficulty concentrating, some joint pain
On 04 July dev rash, some lesions vesicular, some are flat. Lesions on his hands, arms, elbows, knuckles and knees. He has one lesion on his lip. No evidence of EM. SPV site normal. Pt is not ill, c/o itching and some discomfort. Symptoms: RASH&OTH NONSPEC SKIN ERUPTION(R21), PRURITUS, UNSPECIFIED(L299).
Had the shot still got shingles/Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 02-MAR-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The reporter reported that patient had the shot and still got shingles. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 32-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Vitamin supplementation.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 26-Nov-2020 and the estimated date of delivery was 02-Sep-2021. On 25-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  seventeenth week of the pregnancy.  On 25-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound antenatal screen: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 25-Feb-2021 ultrasound genetic testing for chromosome 18,21,13 done, result negative. Past pregnancy included live birth on 19-Jun-2017.
This case was reported by a consumer and described the occurrence of injection site pain in a 63-year-old male patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (as a 15 years old in 1970). Previously administered products included SHINGRIX with an associated reaction of injection site pain (received 1st dose on an unspecified date, for tolerance refer case US2018GSK152189). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, 7 days after receiving SHINGRIX, the patient experienced injection site pain, general body pain, chest pain, pain in arm and feeling hot and cold. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the injection site pain, general body pain, chest pain, pain in arm and feeling hot and cold were recovered/resolved. It was unknown if the reporter considered the injection site pain, general body pain, chest pain, pain in arm and feeling hot and cold to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX and experienced sore at injection site, body aches, chest and left arm pain after a week or so, from the lasts couple of weeks the patient body was experiencing temperature being hot to cold. Less than a year, after receiving the SHINGRIX the patient body being hot to cold like what a women experience with metaphase. At the time of reporting the patient was in fair condition for his age, side effects were almost all gone and said that he hopes this works because the side effects were worse than he remember with shingles as a 15 year old brought on by bad jelly fish sting and he survived and he also said that this information hopefully works on the SHINGRIX research. This case has been linked with case US2018GSK152189, (same patient for 1st dose) reported by the same reporter.
Moderna COVID-19 Vaccine EUA swelling in left hand 45 minutes after injection. Fever of 101, chills, body aches, fatigue and vomiting 4/15 & 4/16 labored breathing and discomfort in lungs when inhaling, fatigue, chills and headache on 4/17 extreme fatigue and diarrhea 4/18 & 4/19 extreme headache, nausea, dizziness and fatigue 4/20 dull droning headache and fatigue 4/21 - 4/23 *pain in lymph nodes (both sides) 4/22
Swelling, induration, redness, pain, and itching within 3 hours of injection extending from left shoulder along deltoid region for 6 inches. Swelling and induration. So far, treating with ibuprofen, Tylenol, ice, Zyrtec.
I received my COVID booster in May 2021 (2nd in the series). I developed Bell's Palsy a week later. It resolved itself after a couple of months.  I experienced quite a bit of pain, was put on steroids and had an MRI. I have a history of Bell's Palsy in 1997 and again in 1999. I reported this to VAERS when this happened in 2021. I received another COVID Booster in Nov 2021. No Bell's Palsy. I received my 4th COVID (Bivalent) as well as my flu vaccine (which I get annually). I developed Bell's Palsy a week later. I have a doctor's appointment in 2 days. No pain but typical Bell's Palsy symptoms and significantly reduced taste. I had not felt 100% when I received my COVID vaccine- I felt like I was coming down with a head cold- but it never turned into anything. I had body aches and my ears hurt  a lot over the 3 days after my COVID and flu vaccination. The body aches were typical as I usually feel bad the day after my COVID vaccination. Both ears hurting was not something I experienced before. I took ibuprofen for the pain and it went away after about 3 days. The Bell's Palsy started 6 days after that.  I have no idea which flu vaccination I received so i was unable to fill out that portion.
Hard swelling over vaccination site on 1/20. It was extremely painful and hot to the touch. On 1/21 red blotchy rash appeared over area.
I started my menstrual cycle on Monday, September 6th. My period consistently lasts 6-7 days. On Thursday, September 9th (4th day of my period), I received my Janssen COVID-19 vaccine in the morning. My menstrual flow ceased the remainder of the day on 9/9. I had no flow on 9/10 or 9/11. On 9/12 (day 6), my period began again, after 4 days of bleeding, and 3 days of no bleeding. It wasn't heavy, just very light. On 9/13 and today 9/14, my period has been so heavy that I am emptying a 30 mL menstrual cup every 50 minutes. It typically takes me 6-12 hours to fill that depending on the day. My period flow consistency right now is extremely abnormal in that it is bright red and watery, with 2-3 quarter sized clots being passed every hour. This is not normal for me. I have had consistently 26-30 day cycles with dark red thick flow for years. Someone has to look into this. Please.
Information has been received from a registered nurse concerning a 44 year old male pt who was vaccinated with Hep B vaccine IM, in the left deltoid. Twelve hours post vax, the pt experienced wheezing and difficulty breathing. Unspecified medical attention was sought. The symptoms stopped within 3 hours of onset. It was reported that the symptoms were not severe enough to be treated. Follow-up information from a registered nurse reported that the pt recovered "without further complaints of difficulty breathing."
both arms are sore; Hard to put her clothes on; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (both arms are sore) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to put her clothes on) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (both arms are sore) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to put her clothes on). At the time of the report, PAIN IN EXTREMITY (both arms are sore) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to put her clothes on) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or medical history provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-067270 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067270:Dose 1
Patient developed itching on thighs, tops of ankles, arms, and ribs. Patient did not develop any shortness of breath. Benadryl liquid 25mg was given at onset of itching. Itching resolved 10 minutes after Benadryl administration. Patient left facility with no complaints.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 67-year-old male patient received bnt162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Acoustic Neuroma (Cause of Left-Ear Deafness)" (unspecified if ongoing); "Stroke" (unspecified if ongoing); "Hypertension" (unspecified if ongoing), notes: since 14; "Colon Cancer (Resection with Chemotherapy)" (unspecified if ongoing); "Heart Ablation" (unspecified if ongoing); "Heart Stenting" (unspecified if ongoing); "Left-Sided Neuropathy" (unspecified if ongoing); "Weakness from Chemotherapy" (unspecified if ongoing); "Weakness from Chemotherapy" (unspecified if ongoing); "Acoustic Neuroma (Cause of Left-Ear Deafness)" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The event "treatment of covid-19" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: home; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course details: The patient was feeling weak, foggy, and disoriented. He took a home Covid-19 test, which was positive. They called the doctor and they ordered Paxlovid for him. The patent started treatment with Paxlovid (oral) on 10Sep2023 for COVID-19 and discontinued on 11Sep2023.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Cellulitis symptoms began 2 days After vaccination. Site continued to grow with streaking from 2-5 days and was extremely sensitive and painful to even the slightest touch. Not able to move arm due to pain. Child began to feel sick with nausea and low grade fever.
Pt. got VZV #2 vaccination 2/29/12 & returned to office 3/2/12 to get PPD read & pt. mentioned her arm at site felt sore & was red/swollen. Dr. looked at site & concluded there was no evidence of infection & advised pt. to apply ice & call back if symptoms persist or worsen.
feels like a headache; feel as if she was having a bad hangover; feels sick; This is a spontaneous report from a contactable consumer. A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 intramuscular on 10Apr2021 (Lot number, Expiration date: unknown) as single dose for covid-19 immunisation. The patients medical history and concomitant medications were not reported. The patient felt like a headache is coming on but it hasn't yet on an unspecified date, felt as if she was having a bad hangover on an unspecified date, felt sick and felt like herself on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Injection site reaction to the Rt. outer V.L. with some erythema on the thigh. Saw Dr. on 8/27/10 & was noted to be a local reaction with erythema without evidence of cellulitis.
rt arm paralyzed for 2 days p/vax;high level of pain, could not lift arm, OTc meds relieve the pain;have appt w/MD;
Extreme arm pain, swelling at injection site as well as intense itching.  Used  extra strength Tylenol, store brand antihistamine and extra strength Benadryl cream.
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 01/28/2021 and 02/18/2021. They presented to emergency department on 10/11/2021 with primary concerns of shortness of breath and fever which had been happening for about 2 days (symptom onset approx. 10/09/2021). They were admitted to hospital on 10/11/2021 and tested positive for COVID-19 upon admission. They experienced complications of COVID-19 pneumonia, septic shock,  and pancytopenia. They remained hospitalized until their death on 10/16/2021.
covid vaccine sickness.  presents with chills, dizziness, n/, coughing, sore and tenderness on injection site a/f 2nd Moderna on 6 Apr.
One week after first Covid vaccine I was diagnosed with atrial fibrillation. Needed treatment. Four hours after second Covid vaccine atrial fibrillation recurred
pt recvd polio vax 25JUN56, 23JUL56 & 1MAY57; pt was dx w/polio in JUL58; pt was hospitalized & suffered permanent damage to lt leg, foot & hip as a result of polio;
This case was reported in a literature article and described the occurrence of vaccination failure in a adolescent subject who received Meningococcal ACWY-CRM vaccine. On an unknown date, an unknown time after receiving Meningococcal ACWY-CRM vaccine, the subject developed vaccination failure. Serious criteria included GSK medically significant. Additional event(s) included meningococcal infection with serious criteria of GSK medically significant. The outcome of vaccination failure was unknown. The outcome(s) of the additional event(s) included meningococcal infection (unknown). It was unknown if the investigator considered the vaccination failure and meningococcal infection to be related to Meningococcal ACWY-CRM vaccine. Additional information was provided. This case was reported in a literature article and described the occurrence of suspected vaccination failure in an adolescent of unspecified gender who was vaccinated with MENVEO (GlaxoSmithKline). No information on patient's medical or family history or concomitant medication or concurrent condition was provided. On an unspecified date in or after 2010, the patient received MENVEO (administration route and site unspecified; dosage unknown; batch number not provided). On an unspecified date, an unknown period after vaccination, the patient developed meningococcal disease. This case has been considered as suspected vaccination failure being time to onset and full schedule was unknown. This case has been considered serious due to suspected vaccination failure. Treatment was unknown. The outcome of the event was not reported. The authors did not comment on the relationship between the event of meningococcal disease and MENVEO. The authors concluded that "MenACWY-D was effective in the first year after vaccination but effectiveness waned 3 to less than 8 years post-vaccination. The estimates of VE from this evaluation informed the Advisory Committee on Immunization Practices in its decision to add a booster dose of MenACWY".
Swollen Left Arm, Rash and Itchiness at the site of the injection that started on 02/15/2021 and is currently still there. My understanding is this is something that last about 7 days.
Information has been received from a 60 year old female licensed practical nurse with allergies to unspecified narcotics and Compazine and no medical history who on 19-MAR-2007 was vaccinated with a dose of Zostavax (lot # 656609/0015U). There was no concomitant medication. On approximately 21-MAR-2007, 24 to 36 hours after vaccination, the patient developed a "light" case of shingles on her back and waist. She went to the emergency room and was prescribed prednisone and Famvir. Unspecified blood work and urology work were performed (results not provided). At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested. 06/22/07 This is in follow-up to report(s) previously submitted on 4/13/2007. Initial and follow-up information has been received from a 60 year old female with allergies to unspecified narcotics and COMPAZINE and no medical history who on 19-MAR-2007 at 16:00 was vaccinated SC in the left upper arm with a first dose of ZOSTAVAX (Oka/Merck) (lot # 656609/0015U). There was no concomitant medication. There was no illness at the time of vaccination. On 19-MAR-2007 at "14:00" the patient developed pain in her right "mid quadrant" and she went to the ER for treatment. On 24-MAR-2007 (previously reported as 24 to 36 hours after vaccination), shingles blisters appeared (reported to be a "light" case of shingles) on her back and waist. She went to the emergency room, labs were performed and the patient was prescribed prednisone 30 mg po bid for 7 days, then 15 mg bid for 7 days, then 15 mg daily for 7 days and FAMVIR 1 capsule po daily. At the time of the report, the patient's recovery status was unknown. A product quality complaint was not involved. The patient had no AE's following prior vaccination. It was noted that the patient works in a hospital environment with patient contact with immunocompromised patients. The patient was enrolled in the VZVIP program: the Varicella Zoster Virus Identification Program enables biological samples to be analyzed by PCR to identify if VZV is present and if it is present to identify if it is associated with the wild-type strain or with the Oka/Merck vaccine VZV strain. Specimens were obtained from large swabs from the patient's throat and back. It was reported that these specimens were inadequate. Additional information has been requested.
Narrative:  Patient is a 78 year old man who received COVID19 vaccine from the clinic on 1/12/21. A half an hour after her received the vaccine, he lowered himself to the ground due to feeling very dizzy and light headed. Per RN note the pt hit his head, however, per ER MD/NP note he denied hitting his head. The patient was hypotensive and bradycardic and brought to the ER where he was treated with a bolus of normal saline. Per post-discharge note, the pt denied any more syncopal episodes however did still feel week.
pt admitted to hospital on 12/3/21 for acute encephalopathy, acute right MCA stroke, cerebral edema; pt had a positive COVID test on 1/17/22; found without breath and pulseless on 2/5/22.  DC and med records sent to info@vaers.org
Pt c/o anxiety towards receiving vaccine. No symptoms associated with allergic reaction observed. Pt alert, oriented, vitals normal. Physical and neurological exams normal. Refused transport to hospital. AMA consent.
fever; gastro; myalgia; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, gastrointestinal disorder and myalgia. On an unknown date, the outcome of the fever, gastrointestinal disorder and myalgia were not recovered/not resolved.   It was unknown if the reporter considered the fever, gastrointestinal disorder and myalgia to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported but selected as an adult as per the vaccine indication. The patient would like to know, what to take to manage severe side effects of Shingrix that he/she had experienced like fever, gastrointestinal disroder and myalgia.